EUVIMEDEUVIMED entdecken
Crossref

Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer

Hanan Fawzy Mohamed Abdallah, Hala Mohamed Ahmed Elshenshawy, Rasha Abd El-Ghany Mohamed Khedr, Maiy Abdul-Raheim Mohammad Alshahat, Amal Ahmed Fouad Halim

Oncology in Clinical Practice · 15.01.2026 · 22

DOI: 10.5603/ocp.109786 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology in Clinical Practice, online erschienen am 15.01.2026. Verfasst von Hanan Fawzy Mohamed Abdallah und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Abdallah, H. F. M., Elshenshawy, H. M. A., Khedr, R. A. E. M., Alshahat, M. A. M., & Halim, A. A. F. (2026). Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer. Oncology in Clinical Practice, 22(0). https://doi.org/10.5603/ocp.109786

Vancouver

Abdallah HFM, Elshenshawy HMA, Khedr RAEM, Alshahat MAM, Halim AAF. Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer. Oncology in Clinical Practice. 2026;22(0). doi:10.5603/ocp.109786

BibTeX
@article{Abdallah2026,
  author = {Abdallah, Hanan Fawzy Mohamed and Elshenshawy, Hala Mohamed Ahmed and Khedr, Rasha Abd El-Ghany Mohamed and Alshahat, Maiy Abdul-Raheim Mohammad and Halim, Amal Ahmed Fouad},
  title = {Acute and late toxicity after moderate hypo-fractionated intensity modulated radiotherapy (IMRT) with simultaneous integrated boost (SIB) for prostate cancer},
  journal = {Oncology in Clinical Practice},
  year = {2026},
  volume = {22},
  number = {0},
  doi = {10.5603/ocp.109786}
}
Kostenlos starten →